1. EP-1592: Impact of 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence after surgery. (April 2018) Authors: Bartoncini, S.; Nicolotti, D.; Deandreis, D.; Guarneri, A.; Zitella, A.; Passera, R.; Parise, R.; Bellò, M.; Lillaz, B.; Bisi, G.; Gontero, P.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lesion dosimetry in metastatic thyroid cancer treated with 131I: standardization of SPECT-TC calculation method with an in-house software tool and preliminary texture analysis results. (December 2021) Authors: Richetta, E.; Poli, M.; Rienzo, A.; Valentini, D.; Garbaccio, V.; Pellerito, R.E.; Muni, A.; Deandreis, D.; Stasi, M. Journal: Physica medica Issue: Volume 92(2021)Supplement Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-0835 68GaPSMA11 PET/CT in prostate cancer patients with biochemical recurrence: PET positivity predictors. (April 2019) Authors: Parise, R.; Bartoncini, S.; Guarneri, A.; Deandreis, D.; Lillaz, B.; Solla, S.D.; Spinelli, L.; Nicolotti, D.; Pilati, E.; Bellò, M.; Passera, R.; Gontero, P.; Bisi, G.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-1335 PSMA-PET impact on post-prostatectomy recurrencies multidisciplinary management: focus on RT. (August 2021) Authors: Chiofalo, V.; Iorio, G.C.; Bonavero, I.; Parise, R.; Carlevato, R.; Bartoncini, S.; Richetto, V.; Ceci, F.; Grimaldi, S.; Dall'Armellina, S.; Deandreis, D.; Lillaz, B.; Oderda, M.; Gontero, P.; Guarneri, A.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-1396 PSMA-PET management of prostate cancer patients relapsing after RP plus prostate-bed radiotherapy. (May 2022) Authors: Chiofalo, V.; Iorio, G.C.; Bonavero, I.; Bartoncini, S.; Richetto, V.; Grimaldi, S.; Dall'Armellina, S.; Deandreis, D.; Lillaz, B.; Oderda, M.; Gontero, P.; Guarneri, A.; Ricardi, U. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗